logo
logo

Aikido Pharma Announces Strategic Investment In Masterclass

Aikido Pharma Announces Strategic Investment In Masterclass

04/05/22, 2:00 PM
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has secured an early equity interest in privately-held Yanka Industries, Inc., doing business as MasterClass (https://www.masterclass.com/). MasterClass is self-described as the "streaming platform where the world's best come together so anyone, anywhere, can access and be inspired by their knowledge and stories. With an annual membership, members get unprecedented access to 150+ instructors and classes across a wide variety of fields, including Arts & Entertainment, Business, Design & Style, Sports & Gaming, Writing and more." (https://www.prnewswire.com/news-releases/masterclass-announces-professional-streamer-tyler-ninja-blevins-to-teach-how-to-become-a-streamer-in-30-days-301497337.html).

Company Info

Company
Master Class
Additional Info
The online education platform offers courses on a broad array of topics and features well-known figures including Malala Yousafzai, Spike Lee, Neil deGrasse Tyson and Ringo Starr. The Company is also developing a broad-spectrum antiviral platform that may potentially inhibit replication of multiple viruses including Influenza virus, SARS-CoV (coronavirus), MERS-CoV, Ebolavirus and Marburg virus. Masterclass Provides Members Access to Pre-Recorded Lectures by Top ExpertsNEW YORK, April 5, 2022 /PRNewswire/ --